top of page
Clinical Trials
Currently enrolling clinical trials at The Center for Gynecologic Oncology at Catholic Health
Schedule your visit with Dr. McEachron today to find out if you are eligibile for clinical trial enrollment
Recurrent Ovarian Cancer
GOG 3086 – REFRaME-O1: A phase 2/3 open-label study evaluating the efficacy and safety of luveltamab tazevibulin (STRO-002) versus investigator’s choice chemotherapy in relapsed platinum-resistant epithelial ovarian cancer (including fallopian tube or primary peritoneal cancers) expressing folate receptor alpha (FOLR1)
Recurrent Endometrial Cancer
GOG 3089 – A Phase 2/3 Study of Navtemadlin (KRT-232) as Maintenance Therapy in Subjects with TP53wt Advanced or Recurrent Endometrial Cancer Who Responded to Chemotherapy
bottom of page